Literature DB >> 19621836

N-acetylcysteine: multiple clinical applications.

Paul J Millea1.   

Abstract

N-acetylcysteine is the acetylated variant of the amino acid L-cysteine and is widely used as the specific antidote for acetaminophen overdose. Other applications for N-acetylcysteine supplementation supported by scientific evidence include prevention of chronic obstructive pulmonary disease exacerbation, prevention of contrast-induced kidney damage during imaging procedures, attenuation of illness from the influenza virus when started before infection, treatment of pulmonary fibrosis, and treatment of infertility in patients with clomiphene-resistant polycystic ovary syndrome. Preliminary studies suggest that N-acetylcysteine may also have a role as a cancer chemopreventive, an adjunct in the eradication of Helicobacter pylori, and prophylaxis of gentamicin-induced hearing loss in patients on renal dialysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19621836

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  83 in total

1.  N-acetylcysteine Protects Mice from High Fat Diet-induced Metabolic Disorders.

Authors:  Yongjie Ma; Mingming Gao; Dexi Liu
Journal:  Pharm Res       Date:  2016-05-09       Impact factor: 4.200

2.  Development of asystole requiring cardiac resuscitation after the administration of regadenoson in a patient with pulmonary fibrosis receiving n-acetylcysteine.

Authors:  Erin C Grady; John T Barron; Robert H Wagner
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

3.  N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.

Authors:  Luís Eduardo S Fontes; Ana Luiza C Martimbianco; Carolina Zanin; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2019-02-12

4.  N-acetylcysteine (NAC) diminishes the severity of PCB 126-induced fatty liver in male rodents.

Authors:  Ian K Lai; Kiran Dhakal; Gopi S Gadupudi; Miao Li; Gabriele Ludewig; Larry W Robertson; Alicia K Olivier
Journal:  Toxicology       Date:  2012-07-21       Impact factor: 4.221

5.  N-Acetyl-l-cysteine effects on multi-species oral biofilm formation and bacterial ecology.

Authors:  K Rasmussen; J Nikrad; C Reilly; Y Li; R S Jones
Journal:  Lett Appl Microbiol       Date:  2015-12-09       Impact factor: 2.858

6.  The potential role of N-acetylcysteine for the treatment of Helicobacter pylori.

Authors:  Kian Makipour; Frank K Friedenberg
Journal:  J Clin Gastroenterol       Date:  2011 Nov-Dec       Impact factor: 3.062

7.  N-acetyl-L-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway.

Authors:  Suparna Qanungo; Joachim D Uys; Yefim Manevich; Anne M Distler; Brooke Shaner; Elizabeth G Hill; John J Mieyal; John J Lemasters; Danyelle M Townsend; Anna-Liisa Nieminen
Journal:  Biomed Pharmacother       Date:  2014-08-28       Impact factor: 6.529

Review 8.  Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

Authors:  D Lynn Kirkpatrick; Garth Powis
Journal:  Antioxid Redox Signal       Date:  2016-04-22       Impact factor: 8.401

Review 9.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

10.  Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease.

Authors:  Benjamin R Underwood; Sara Imarisio; Angeleen Fleming; Claudia Rose; Gauri Krishna; Phoebe Heard; Marie Quick; Viktor I Korolchuk; Maurizio Renna; Sovan Sarkar; Moisés García-Arencibia; Cahir J O'Kane; Michael P Murphy; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-06-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.